Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR-ABL tyrosine kinase, CGP 57148

Cell Death and Differentiation

Volumn 5, Issue 8, 1998, Pages 710-715

  Dan, Shingo ^a   Naito, Mikihiko ^a   Tsuruo, Takashi ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

Apoptosis; BCR ABL; CML; K562; KYO 1

Indexed keywords

BCR ABL PROTEIN; DNA FRAGMENT; ENZYME INHIBITOR; IMATINIB; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RETINOBLASTOMA PROTEIN;

APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0031869466     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400400     Document Type: Article

References (28)

1. An B and Dou QP (1996) Cleavage of retinoblastoma protein during apoptosis. an interleukin β-converting enzyme-like proteass as candidate Cancer Res. 56: 438-442
2. Andoniou CE, Thien CB, and Langdon WY (1994) Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene EMBO J 13: 4515-4523
3. Berry DE, Lu Y, Schmidt B, Fallon PG, O'Connell C, Hu SX, Xu HJ and Blanck G (1996) Retinoblastoma protein inhibits IFN-γ-induced apoptosis. Oncogene 12 1809-1819
4. Buchdunger E, Zimmermann J, Mett H, Meyer T, Muller M, Druker BJ and Lydon NB (1996) Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res. 56: 100-104
5. Cortez D, Stoica G, Pierce JH and Pendergast AM (1996) The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway Oncogene 13: 2589-2594
6. de Klein A, van Kessei AG, Grosveld G, Bartram CR, Hagemeijer A, Bootsma D, Spurr NK, Heisterkamp N, Groffen J and Stephenson JR (1982) A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia Nature 300: 765-767
7. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J and Lydon NB (1996) Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat. Med. 2: 561-566
8. Fujita N, Kataoka S, Naito M, Heike Y, Boku N, Nakajima M and Tsuruo T (1993) Suppression of T-lymphoma cell apoptosis by monoclonal antibodies raised against cell surface adhesion molecules. Cancer Res. 53: 5022-5027
9. Heisterkamp N, Jenster G, ten Hoeve J, Zovich D, Pattengale PK and Groffen J (1990) Acute leukaemia in bcr/abl transgenic mice. Nature 344: 251-253
10. 1 trsnslocation. Nature 315: 758-761
11. Heisterkamp N, Stephenson JR, Groffen J, Hansen PF, de Klein A, Bartram CR and Grosveld G (1983) Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature 306: 239-242
12. Janicke RU, Walker PA, Lin XY and Porter AG (1996) Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J. 15: 6969-6978
13. Mandanas RA, Leibowitz DS, Gharehbaghi K, Tauchi T, Burgess GS, Miyazawa K, Jayaram HN and Boswell HS (1993) Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells. Blood 82: 1838-1847
14. Martin SJ and Green DR (1995) Protease activation during apoptosis: death by a thousand cuts ? Cell 82: 349-352
15. Mashima T, Naito M, Kataoka S, Kawai H and Tsuruo T (1995a) Aspartate-based inhibitor of interleukin-1β-converting enzyme prevents antitumor agent-induced apoptosis in human myeloid leukemia U937 cells. Biochem. Biophys. Res, Commun. 209: 907-915
16. Mashima T Naito M. Fujita N, Noguchi K and Tsuruo T (1995b) Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis. BioChem. Biophys. Res. Commun 217: 1185-1192
17. McConkey DJ, Goodrich D, Bucana C and Kiostergaard J (1996) The human retinoblastoma gene product suppresses ceramide-induced apoptosis in human bladder tumor cells. Oncogene 13: 1693-1700
18. McGahon A, Bissonnette R, Schmitt M, Cotter KM, Green DR and Cotter TG (1994) BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood 83: 1179-1187
19. Narto M, Nagashima K, Mashima T and Tsuruo T (1997) Phosphatidylserine externalization is a downstream event of interleukin-1β-converting enzyme family protease activation during apoptosis. Blood 89: 2060-2066
20. Nichols GL, Raines MA, Vera JC, Lacomis L, Tempst P and Golde DW (1994) Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells. Blood 84: 2912-2918
21. Noguchi K, Naito M, Oshimura M, Mashima T, Fujita N, Yonehara S and Tsuruo T (1996) Chromosome 22 complements apoptosis in Fas-and TNF-resistant mutant UK110 cells. Oncogene 13: 39-46
22. Oda T, Heaney C, Hagopian JR, Okuda K, Griffin JD and Druker BJ (1994) Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia J. Bioi. Chem. 269: 22925-22928
23. Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J et al. (1993) BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 75: 175-185
24. Sattler M, Salgia R, Okuda K, Uemura N, Durstin MA, Pisick E, Xu G, Li JL, Prasad KV and Griffin JD (1996) The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3′ kinase pathway. Oncogene 12: 839-846
25. Skorski T, Kanakaraj P, Nieborowska-Skorska M, Ratajczak MZ, Wen SC, Zon G, Gewirtz AM, Perussia B and Calabretta B (1995) Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells. Blood 86: 726-736
26. Tomida A, Suzuki H, Kim HD and Tsuruo T (1996) Glucose-regulated stresses cause decreased expression of cyclin D1 and hypophosphorylation of retinoblastoma protein in human cancer cells. Oncogene 13: 2699-2705
27. Vaux DL and Strasser A (1996) The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA 93: 2239-2244
28. Wang J, Guo K, Wills KN and Walsh K (1997) Rb functions to inhibit apoptosis during myocyte differentiation. Cancer Res. 57: 351-354